Long-term Review of a Cohort of Arthroscopic Bankart Interventions (ISIS-2017)

August 29, 2018 updated by: Rennes University Hospital

Recurrent instability is the most common chronic shoulder pathology of the young and athletic patient. It is a source of functional, sporting and professional disability, and a permanent apprehension to the use of the affected shoulder.

Surgical treatment has been proposed for a long time by the reintegration of the labrum (intervention of Bankart) then by the making of an osteo-muscular stop (intervention of Latarjet).

Like in many domains, surgical techniques have evaluated towards the search for endoscopic alternatives to open surgery, more deleterious.

Bankart's intervention has been performed arthroscopically since the 1980s and remains the majority intervention in the United States. However, its success rate never reached that of open techniques, Bankart and Latarjet. Surgeons therefore sought the predictors of these failures in order to define the limits of the indications for arthroscopic Bankart intervention.

The determination and use of the preoperative instability score (Instability Severity Index Score : ISIS) described by Balg and Boileau is one of the ways to clarify these indications.

The aim of this study is to prospectively establish the values of the ISIS score to obtain an acceptable recurrence rate of long-term instability

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aix En Provence, France, 13100
        • Clinique parc Rambot Provençale
      • Annecy, France, 74000
        • Clinique Générale d'Annecy
      • Boulogne-Billancourt, France, 92100
        • Hopital Ambroise Pare
      • Cambrai, France, 59400
        • Clinique du Cambresis
      • Echirolles, France, 38432
        • Clinique des Cèdres
      • Le Havre, France, 76600
        • Clinique François 1er
      • Mérignac, France, 33700
        • Clinique du Sport de Bordeaux-Mérignac
      • Nice, France, 06202
        • Hôpital ARCHET II
      • Paris, France, 75008
        • Clinique Turin
      • Paris, France, 75000
        • Hôpital Saint-Antoine / APHP
      • Rennes, France
        • Centre hospitalier universitaire de Rennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients operated between December 2007 and December 2008 for recurrent shoulder instability, according to the arthroscopic procedure (Arthroscopic Bankart)

Description

Inclusion Criteria:

  • Major patient
  • Patient who already volunteered in a first ISIS study

Inclusion Criteria of the ISIS Study:

  • Patients operated between December 2007 and December 2008 for recurrent shoulder instability, according to the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of the indication of operation an ISIS score of ≤ 4 points (regardless of the positive criteria) (see Annex 2- ISIS score)
  • Age> 16 years
  • Supported by a joint arthroscopic technique completed.
  • Patient not objecting to his participation in the study

Exclusion Criteria (same as those of the ISIS study)

  • First dislocation or resumption of another technique at the time of indication for surgery
  • Voluntary or multidirectional instability at the time of the indication of operation
  • Painful shoulder without instability felt at the time of the operative indication
  • Lesion of the cap (perioperative report)
  • Humeral lesions Avulsion Gleno-humeral Ligament (per-operative finding)
  • Unsuccessful technique
  • Major benefiting from a legal protection measure (safeguard of justice, trusteeship, guardianship)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ISIS cohort

Patients operated between December 2007 and December 2008 for recurrent shoulder instability using the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of indication for surgery an ISIS score ≤ 4 points

Phone follow-up

Through a short phone interview :

  • Determination of a complication (Infection, capsulitis, recurrence)
  • Determination of the Rowe score
  • Determination of the Walch-Duplay score

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of instability recurrence after arthroscopic Bankart intervention
Time Frame: Through study completion, 2 months on average
The rate of instability recurrence 9 years after an arthroscopic Bankart intervention, is derived from the patient's responses to the interview
Through study completion, 2 months on average

Secondary Outcome Measures

Outcome Measure
Time Frame
Predictive value of the ISIS score in the occurrence of recurrence of instability
Time Frame: Through study completion, 2 months on average
Through study completion, 2 months on average

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hervé THOMAZEAU, MD, PhD, Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 7, 2017

Primary Completion (Actual)

November 9, 2017

Study Completion (Actual)

November 9, 2017

Study Registration Dates

First Submitted

August 28, 2018

First Submitted That Met QC Criteria

August 29, 2018

First Posted (Actual)

August 31, 2018

Study Record Updates

Last Update Posted (Actual)

August 31, 2018

Last Update Submitted That Met QC Criteria

August 29, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 35RC17_3025
  • 2017-A01665-48 (Other Identifier: Id-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recurrent Anterior Shoulder Instability

Clinical Trials on Phone follow-up

3
Subscribe